159 related articles for article (PubMed ID: 8425845)
1. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
Milam AH; Saari JC; Jacobson SG; Lubinski WP; Feun LG; Alexander KR
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):91-100. PubMed ID: 8425845
[TBL] [Abstract][Full Text] [Related]
2. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
[TBL] [Abstract][Full Text] [Related]
4. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
[TBL] [Abstract][Full Text] [Related]
5. [Melanoma-associated retinopathy with night blindness. Case report].
Klopfer M; Schmidt T; Leipert KP; Ugi I; Boeck K; Hofmann S
Ophthalmologe; 1997 Aug; 94(8):563-7. PubMed ID: 9376694
[TBL] [Abstract][Full Text] [Related]
6. Retinal findings in melanoma-associated retinopathy.
Borkowski LM; Grover S; Fishman GA; Jampol LM
Am J Ophthalmol; 2001 Aug; 132(2):273-5. PubMed ID: 11476700
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.
Potter MJ; Thirkill CE; Dam OM; Lee AS; Milam AH
Ophthalmology; 1999 Nov; 106(11):2121-5. PubMed ID: 10571347
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
[TBL] [Abstract][Full Text] [Related]
9. Mitofilin and titin as target antigens in melanoma-associated retinopathy.
Pföhler C; Preuss KD; Tilgen W; Stark A; Regitz E; Fadle N; Pfreundschuh M
Int J Cancer; 2007 Feb; 120(4):788-95. PubMed ID: 17131336
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3.
Duvoisin RM; Haley TL; Ren G; Strycharska-Orczyk I; Bonaparte JP; Morgans CW
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2732-2738. PubMed ID: 28549093
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.
Varin J; Reynolds MM; Bouzidi N; Tick S; Wohlschlegel J; Becquart O; Michiels C; Dereure O; Duvoisin RM; Morgans CW; Sahel JA; Samaran Q; Guillot B; Pulido JS; Audo I; Zeitz C
PLoS One; 2020; 15(4):e0231750. PubMed ID: 32324760
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.
Aronow ME; Adamus G; Abu-Asab M; Wang Y; Chan CC; Zakov ZN; Singh AD
Surv Ophthalmol; 2012 Nov; 57(6):558-64. PubMed ID: 22784677
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells.
Dhingra A; Fina ME; Neinstein A; Ramsey DJ; Xu Y; Fishman GA; Alexander KR; Qian H; Peachey NS; Gregg RG; Vardi N
J Neurosci; 2011 Mar; 31(11):3962-7. PubMed ID: 21411639
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.
Pföhler C; Haus A; Palmowski A; Ugurel S; Ruprecht KW; Thirkill CE; Tilgen W; Reinhold U
Br J Dermatol; 2003 Jul; 149(1):74-8. PubMed ID: 12890197
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-associated retinopathy: does autoimmunity prolong survival?
Chan C; O'Day J
Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
[TBL] [Abstract][Full Text] [Related]
19. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
Keltner JL; Thirkill CE; Yip PT
J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
